Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,806 USD | -1,71% | -16,69% | -11,67% |
13/03 | Transcript : Gossamer Bio, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 07:30 AM | |
12/03 | Gossamer Bio kondigt benoeming in Raad van Bestuur aan | CI |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 185 mln. 174 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -180 mln. -169 mln. | Nettowinst (verlies) 2025 * | -196 mln. -184 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 13,32 mln. 12,52 mln. | Nettoliquiditeiten 2025 * | 23,83 mln. 22,4 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,09
x | K/w-verhouding 2025 * |
-1,14
x | Werknemers | 135 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,76% |
Recentste transcriptie over Gossamer Bio, Inc.
1 dag | -1,71% | ||
1 week | -16,69% | ||
Lopende maand | -31,69% | ||
1 maand | -41,59% | ||
3 maanden | -7,32% | ||
6 maanden | +34,33% | ||
Lopend jaar | -11,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 25-10-15 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 07-05-18 |
Chief Tech/Sci/R&D Officer | - | 03-10-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 25-10-15 |
Thomas Daniel
BRD | Director/Board Member | 69 | 01-01-18 |
Skye Drynan
BRD | Director/Board Member | - | 11/03 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.08% | 0 M€ | 0,00% | - | |
0.02% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 0,806 | -1,71% | 768 384 |
17-04-24 | 0,82 | -0,10% | 936 597 |
16-04-24 | 0,8208 | -4,35% | 771 055 |
15-04-24 | 0,8581 | -4,14% | 915 642 |
12-04-24 | 0,8952 | -7,47% | 1 377 573 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-11,67% | 185 mln. | |
-1,82% | 41,36 mld. | |
+44,25% | 41,3 mld. | |
+2,56% | 39,61 mld. | |
-12,11% | 25,62 mld. | |
+3,09% | 24,09 mld. | |
-24,16% | 18,38 mld. | |
+22,12% | 11,85 mld. | |
-3,74% | 11,82 mld. | |
+7,75% | 11,07 mld. |